[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Patient Information Sheet
Rizatriptan benzoate (marketed as Maxalt and Maxalt-MLT)

This is a summary of the most important information about Maxalt.  For details, talk to your healthcare professional.


FDA ALERT [7/2006] – Possible Life-Threatening Threatening Serotonin Syndrome When Used With SSRI or SNRI Medicines

A life-threatening condition called serotonin syndrome can happen when medicines called 5-hydroxytryptamine receptor agonists (triptans), such as Maxalt, and medicines used to treat depression and mood disorders called selective serotonin reuptake inhibitors (SSRIs) or selective serotonin/norepinephrine reuptake inhibitors (SNRIs), are used together.  Signs and symptoms of serotonin syndrome include the following:

  • restlessness
  • hallucinations
  • loss of coordination
  • fast heart beat
  • increased body temperature
  • fast changes in blood pressure
  • overactive reflexes
  • diarrhea
  • coma
  • nausea
  • vomiting

Serotonin syndrome may be more likely to occur when starting or increasing the dose of a triptan, SSRI, or SNRI.  This information comes from reports sent to FDA and knowledge of how these medicines work.  If you take medicines for depression or mood disorders, ask your healthcare professional if your medicine is an SSRI or SNRI.

Before you take Maxalt and an SSRI or SNRI together, talk to your healthcare professional.  If you must take these medicines together, be aware of the possibility of serotonin syndrome, and get medical care right away if you think serotonin syndrome is happening to you. 

This information reflects FDA’s current analysis of data available to FDA concerning this drug. FDA intends to update this sheet when additional information or analyses become available.

What Is Maxalt?

Maxalt is used for the short term treatment of most types of migraine attacks in adults. Maxalt is not used to prevent migraines, or to decrease the number of migraine attacks. Maxalt has not been shown to treat cluster headaches.

Who Should Not Take Maxalt?

You should not take Maxalt if you have (or have had) any of following conditions:

  • uncontrolled high blood pressure 
  • heart disease or a history of heart disease 
  • hemiplegic or basilar migraine (if you are not sure about this, ask your healthcare professional) 
  • stroke 
  • circulation (blood flow) problems to your arms, legs, and bowels 
  • have taken another migraine medicine in the same drug class as Maxalt or other migraine medicines that contain ergotamine, dihydroergotamine, or methylsergide in the last 24 hours (ask your healthcare professional for a list of these medicines if you are unsure)
  • take a monoamine oxidase (MAO) inhibitor medicine or have taken a MAO inhibitor in the past 2 weeks
  • phenylketonuric patients should not take Maxalt-MLT(orally disintegrating tablets), because they contain phenylalanine (an ingredient in aspartame)

What Are The Risks?

The following are the major potential risks and side effects of Maxalt therapy. However, this list is not complete.

Some signs of rare but serious side effects include:

  • Possible life-threatening serotonin syndrome when used with SSRI or SNRI  medicines:  See FDA Alert [07/2006] above.
  • Pain, pressure or tightness in the chest or throat. If severe, or does not go away, call your healthcare professional right away. If this happens at all, discuss with your healthcare professional before taking any more Maxalt.
  • Rarely, people have a serious allergic reaction to Maxalt. This could cause shortness of breath, wheeziness, heart throbbing, swelling of eyelids, face, or lips, or a skin rash, lumps or hives. If this happens, tell your healthcare professional right away.

Other side effects may include:

  • chest heaviness, or pressure
  • tiredness
  • dizziness
  • sleepiness

What Should I Tell My Healthcare Professional?

Before you start taking Maxalt, tell your healthcare professional if you:

  • are trying to become pregnant, are already pregnant, or are breastfeeding 
  • have risk factors for heart disease including:
  • high cholesterol
  • high blood pressure,
  • obesity
  • diabetes
  • smoking
  • strong family history of heart disease
  • postmenopausal female,
  • or a male over 40

Can Other Medicines Or Food Affect Maxalt?

Maxalt and certain other medicines can interact with each other. Tell your healthcare professional about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements.  Some medicines may affect how Maxalt works or Maxalt may affect how your other medicines work.  Know the medicines you take. Keep a list of them with you to show your healthcare professional.

Especially tell your healthcare professional if you:

  • take a SSRI or SNRI medicine
  • have taken another migraine medicine in the same drug class as Maxalt or other migraine medicines that contain ergotamine, dihydroergotamine, or methylsergide in the last 24 hours.
  • take a  monoamine oxidase (MAO) inhibitor medicine or have taken a MAO inhibitor in the past 2 weeks
  • take propranolol

Ask your healthcare professional if you are not sure about the types of medicines you take.

Date this drug approved 06/1998
Patient Information Sheet Revised 07/2006

to top arrow Back to Top     back arrow Back to Triptans  

Date created: July 19, 2006

horizonal rule